• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Get a Second Opinion Emerges from Stealth with AI-Powered Medication Analysis Platform

by Syed Hamza Sohail 05/28/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Get a Second Opinion Inc. has officially emerged from stealth mode, unveiling its AI-powered platform designed to transform how patients understand and manage their medications.

– By analyzing a vast body of FDA data, clinical studies, and real-world outcomes, the company offers personalized insights that help patients make more informed decisions about prescription and over-the-counter (OTC) treatments.

Get a Second Opinion Launches AI-Driven Medication Analysis Platform to Empower Patients

The platform aims to close critical gaps in healthcare decision-making. According to the Mayo Clinic, nearly 70% of Americans take at least one prescription medication, and nearly half take two or more. Yet 76% of patients leave medical appointments confused, with 8 in 10 turning to online searches to clarify treatment options. Cost is another barrier: despite $30 billion in annual pharmaceutical marketing, almost one-third of Americans skip prescriptions due to affordability concerns.

Get a Second Opinion’s technology addresses these challenges through two key features:

·       The Discovery Tool analyzes a single medication or condition in the context of an individual’s health profile. It generates a report ranking potential options, supported by clinical data and cost comparisons—often surfacing more effective and affordable alternatives with fewer side effects.

·       The Planner reviews up to 10 medications across 10 conditions at once, identifying optimized treatment combinations while minimizing adverse interactions and redundant therapies.

According to CEO Joel Ferman, the platform empowers users to become “confident advocates” in their care by delivering insights in minutes that would traditionally take medical professionals weeks to compile.

Founded by two seasoned technology entrepreneurs with personal experience navigating the U.S. healthcare system, Get a Second Opinion was born out of frustration with opaque treatment plans and avoidable side effects. Their solution is built entirely in-house, with all data securely stored on domestic servers to ensure compliance and privacy.

By helping patients evaluate efficacy, safety, and affordability, Get a Second Opinion positions itself as a critical tool for improving health literacy and shared decision-making in an increasingly complex treatment landscape.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |